These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 35214019)
1. Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation. Galindo R; Sánchez-López E; Gómara MJ; Espina M; Ettcheto M; Cano A; Haro I; Camins A; García ML Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214019 [TBL] [Abstract][Full Text] [Related]
2. Cell penetrating peptides-functionalized Licochalcone-A-loaded PLGA nanoparticles for ocular inflammatory diseases: Evaluation of in vitro anti-proliferative effects, stabilization by freeze-drying and characterization of an in-situ forming gel. Galindo-Camacho RM; Haro I; Gómara MJ; Espina M; Fonseca J; Martins-Gomes C; Camins A; Silva AM; García ML; Souto EB Int J Pharm; 2023 May; 639():122982. PubMed ID: 37116598 [TBL] [Abstract][Full Text] [Related]
3. Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders. Silva-Abreu M; Calpena AC; Espina M; Silva AM; Gimeno A; Egea MA; García ML Pharm Res; 2018 Jan; 35(1):11. PubMed ID: 29299768 [TBL] [Abstract][Full Text] [Related]
4. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization. Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710 [TBL] [Abstract][Full Text] [Related]
5. Development of topical eye-drops of lactoferrin-loaded biodegradable nanoparticles for the treatment of anterior segment inflammatory processes. López-Machado A; Díaz N; Cano A; Espina M; Badía J; Baldomà L; Calpena AC; Biancardi M; Souto EB; García ML; Sánchez-López E Int J Pharm; 2021 Nov; 609():121188. PubMed ID: 34655707 [TBL] [Abstract][Full Text] [Related]
6. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization. Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747 [TBL] [Abstract][Full Text] [Related]
7. Enhancing the efficacy of fluocinolone acetonide by encapsulating with PLGA nanoparticles and conjugating with linear PEG polymer. Pinto J; Ahmad M; Guru BR J Biomater Sci Polym Ed; 2019 Sep; 30(13):1188-1211. PubMed ID: 31215325 [TBL] [Abstract][Full Text] [Related]
8. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis. Öztürk AA; Namlı İ; Güleç K; Kıyan HT Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668 [TBL] [Abstract][Full Text] [Related]
9. Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study. Sánchez-López E; Esteruelas G; Ortiz A; Espina M; Prat J; Muñoz M; Cano A; Calpena AC; Ettcheto M; Camins A; Alsafi Z; Souto EB; García ML; Pujol M Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32290252 [TBL] [Abstract][Full Text] [Related]
10. Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment. Esteruelas G; Halbaut L; García-Torra V; Espina M; Cano A; Ettcheto M; Camins A; Souto EB; Luisa García M; Sánchez-López E Int J Pharm; 2022 Jan; 612():121379. PubMed ID: 34915146 [TBL] [Abstract][Full Text] [Related]
11. Ocular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides. Gonzalez-Pizarro R; Parrotta G; Vera R; Sánchez-López E; Galindo R; Kjeldsen F; Badia J; Baldoma L; Espina M; García ML Nanomedicine (Lond); 2019 Dec; 14(23):3089-3104. PubMed ID: 31769335 [No Abstract] [Full Text] [Related]
12. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody. Eivazi N; Rahmani R; Paknejad M Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796 [TBL] [Abstract][Full Text] [Related]
13. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration. Cañadas C; Alvarado H; Calpena AC; Silva AM; Souto EB; García ML; Abrego G Int J Pharm; 2016 Sep; 511(2):719-27. PubMed ID: 27480398 [TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease. Fan S; Zheng Y; Liu X; Fang W; Chen X; Liao W; Jing X; Lei M; Tao E; Ma Q; Zhang X; Guo R; Liu J Drug Deliv; 2018 Nov; 25(1):1091-1102. PubMed ID: 30107760 [TBL] [Abstract][Full Text] [Related]
15. PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium. Gholizadeh S; Kamps JAAM; Hennink WE; Kok RJ Int J Pharm; 2018 Sep; 548(2):747-758. PubMed ID: 29042337 [TBL] [Abstract][Full Text] [Related]
16. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab. Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558 [TBL] [Abstract][Full Text] [Related]
17. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization. Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384 [TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258 [TBL] [Abstract][Full Text] [Related]
19. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ Amin FU; Shah SA; Badshah H; Khan M; Kim MO J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812 [TBL] [Abstract][Full Text] [Related]
20. PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization. Sánchez-López E; Egea MA; Cano A; Espina M; Calpena AC; Ettcheto M; Camins A; Souto EB; Silva AM; García ML Colloids Surf B Biointerfaces; 2016 Sep; 145():241-250. PubMed ID: 27187188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]